Trials / Completed
CompletedNCT01083498
Fractional Laser as Treatment Option for Various Pigment Disorders
Ablative Fractional Laser Therapy as Treatment for Becker's Nevus; a Pilot Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Netherlands Institute for Pigment Disorders · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the use of ablative fractional laser is effective in the treatment of Becker's nevus.
Detailed description
Becker's nevus (BN) is an uncommon pigment disorder of the epidermis characterized by increased pigmentation, a slightly elevated, verrucous surface of the affected skin and sometimes hyperpigmentation. No effective treatment is available. Several laser modalities have been applied in the treatment of Becker's nevus in uncontrolled studies with varying results. Recently, fractional laser therapy was suggested as treatment option for Becker's nevus. In fractional laser therapy, microscopic columns of skin are coagulated or ablated, leaving the surrounding tissue intact, which enhances healing of the treated skin. In this study, the efficacy and safety of ablative fractional laser therapy was assessed in the treatment of Becker's nevus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ablative fractional laser therapy | 10,600 nm ablative fractional laser Irradiance: 10 mJ/microbeam. Coverage: 35-45%. Number of treatment sessions: 3 |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2010-03-09
- Last updated
- 2010-03-09
Source: ClinicalTrials.gov record NCT01083498. Inclusion in this directory is not an endorsement.